Host Vesicle Fusion Protein VAPB Contributes to the Nuclear Egress Stage of Herpes Simplex Virus Type-1 (HSV-1) Replication.
Animals
Cell Nucleus
/ metabolism
Chlorocebus aethiops
HeLa Cells
Herpes Simplex
/ metabolism
Herpesvirus 1, Human
/ physiology
Humans
Intracellular Membranes
/ metabolism
Membrane Fusion
Microsomes
/ metabolism
Nuclear Envelope
/ metabolism
Vero Cells
Vesicular Transport Proteins
/ metabolism
Viral Proteins
/ metabolism
Virion
/ metabolism
Virus Release
/ physiology
Virus Replication
/ physiology
VAPB
herpes simplex virus-1 (HSV-1)
nuclear egress
nuclear envelope
nuclear membrane protein
vesicle fusion protein (VFP)
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
03 02 2019
03 02 2019
Historique:
received:
22
10
2018
revised:
28
01
2019
accepted:
31
01
2019
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
6
2
2019
Statut:
epublish
Résumé
The primary envelopment/de-envelopment of Herpes viruses during nuclear exit is poorly understood. In Herpes simplex virus type-1 (HSV-1), proteins pUL31 and pUL34 are critical, while pUS3 and some others contribute; however, efficient membrane fusion may require additional host proteins. We postulated that vesicle fusion proteins present in the nuclear envelope might facilitate primary envelopment and/or de-envelopment fusion with the outer nuclear membrane. Indeed, a subpopulation of vesicle-associated membrane protein-associated protein B (VAPB), a known vesicle trafficking protein, was present in the nuclear membrane co-locating with pUL34. VAPB knockdown significantly reduced both cell-associated and supernatant virus titers. Moreover, VAPB depletion reduced cytoplasmic accumulation of virus particles and increased levels of nuclear encapsidated viral DNA. These results suggest that VAPB is an important player in the exit of primary enveloped HSV-1 virions from the nucleus. Importantly, VAPB knockdown did not alter pUL34, calnexin or GM-130 localization during infection, arguing against an indirect effect of VAPB on cellular vesicles and trafficking. Immunogold-labelling electron microscopy confirmed VAPB presence in nuclear membranes and moreover associated with primary enveloped HSV-1 particles. These data suggest that VAPB could be a cellular component of a complex that facilitates UL31/UL34/US3-mediated HSV-1 nuclear egress.
Identifiants
pubmed: 30717447
pii: cells8020120
doi: 10.3390/cells8020120
pmc: PMC6406291
pii:
doi:
Substances chimiques
VAPB protein, human
0
Vesicular Transport Proteins
0
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 092076
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 095209
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 109089
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/7
Pays : United Kingdom
Références
Cell. 2003 Feb 21;112(4):519-33
pubmed: 12600315
Trends Cell Biol. 2008 Jun;18(6):282-90
pubmed: 18468439
Nat Commun. 2014 Jun 11;5:4131
pubmed: 24916797
Cell Microbiol. 2013 Feb;15(2):170-8
pubmed: 23057731
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10187-92
pubmed: 17548810
Acta Neuropathol. 2015 Nov;130(5):679-97
pubmed: 26298469
J Virol. 2009 May;83(10):4757-65
pubmed: 19279117
J Cell Sci. 2012 Jun 15;125(Pt 12):2831-6
pubmed: 22454507
J Virol. 2001 Jun;75(12):5697-702
pubmed: 11356979
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7241-6
pubmed: 17426144
Nat Commun. 2014 Jun 03;5:3996
pubmed: 24893131
J Gen Virol. 2001 Oct;82(Pt 10):2363-2371
pubmed: 11562530
J Gen Virol. 1997 Jan;78 ( Pt 1):83-9
pubmed: 9010289
Cold Spring Harb Perspect Biol. 2014 Oct 23;6(11):a022616
pubmed: 25341920
EMBO J. 2013 Jul 17;32(14):2056-72
pubmed: 23736259
J Virol. 2002 Sep;76(17):8939-52
pubmed: 12163613
Biochem Biophys Res Commun. 1999 Jan 8;254(1):21-6
pubmed: 9920726
J Cell Biol. 1995 Jul;130(1):15-27
pubmed: 7790369
Bioinformatics. 2009 Jan 15;25(2):288-9
pubmed: 19033274
J Virol. 2005 Nov;79(21):13473-82
pubmed: 16227268
J Virol. 2015 Aug;89(15):7799-812
pubmed: 25995262
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
pubmed: 24226387
J Gen Virol. 2009 Mar;90(Pt 3):579-590
pubmed: 19218202
Hum Mol Genet. 2012 Mar 15;21(6):1299-311
pubmed: 22131369
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D452-5
pubmed: 14681455
J Virol. 2000 Dec;74(23):11322-8
pubmed: 11070032
J Virol. 1992 Oct;66(10):5999-6007
pubmed: 1527849
J Virol. 2011 Aug;85(16):8012-21
pubmed: 21680502
J Virol. 1992 Jan;66(1):554-61
pubmed: 1309262
J Neurochem. 2011 Apr;117(2):286-94
pubmed: 21275991
J Med Microbiol. 2012 Dec;61(Pt 12):1637-43
pubmed: 23002061
EMBO J. 2003 May 1;22(9):2025-35
pubmed: 12727870
Mol Biol Cell. 2008 Sep;19(9):3871-84
pubmed: 18614794
Nature. 2015 Jun 11;522(7555):236-9
pubmed: 26040713
J Biol Chem. 2009 May 15;284(20):13766-77
pubmed: 19289470
Science. 2002 Aug 2;297(5582):854-7
pubmed: 12161659
J Cell Biol. 2004 Dec 20;167(6):1051-62
pubmed: 15611332
EMBO J. 1994 May 1;13(9):2044-55
pubmed: 8187758
Cell. 2015 Dec 17;163(7):1692-701
pubmed: 26687357
PLoS Pathog. 2015 Jul 22;11(7):e1005059
pubmed: 26200910
Nat Biotechnol. 2001 Mar;19(3):242-7
pubmed: 11231557
PLoS Pathog. 2012 Sep;8(9):e1002904
pubmed: 22969426
Methods Mol Biol. 2006;328:159-75
pubmed: 16785648
Anal Chem. 2010 Mar 15;82(6):2272-81
pubmed: 20166708
Immunology. 2006 Feb;117(2):167-76
pubmed: 16423052
Mol Cell Proteomics. 2010 Dec;9(12):2571-85
pubmed: 20693407
J Biol Chem. 2010 Apr 30;285(18):13839-49
pubmed: 20207736
J Gen Virol. 2007 Oct;88(Pt 10):2642-50
pubmed: 17872514
J Cell Biol. 1973 May;57(2):551-65
pubmed: 4121290
J Cell Biol. 2011 Apr 4;193(1):109-23
pubmed: 21444689
J Virol. 2009 Nov;83(22):11847-56
pubmed: 19759132
J Virol. 2001 Apr;75(8):3675-84
pubmed: 11264357
Virus Res. 2009 Aug;143(2):222-34
pubmed: 19651457
J Virol. 2011 Jul;85(14):7203-15
pubmed: 21561917
EMBO J. 2012 Nov 5;31(21):4204-20
pubmed: 22990238
J Proteome Res. 2002 Jan-Feb;1(1):21-6
pubmed: 12643522
Nat Rev Microbiol. 2011 May;9(5):382-94
pubmed: 21494278
J Biol Chem. 2014 Dec 26;289(52):35795-805
pubmed: 25355318
Virology. 2006 Apr 10;347(2):261-76
pubmed: 16427676
Rapid Commun Mass Spectrom. 2004;18(18):2162-8
pubmed: 15317041
Nat Rev Mol Cell Biol. 2001 Feb;2(2):107-17
pubmed: 11252952
J Cell Biol. 2015 Jun 8;209(5):687-703
pubmed: 26056139
J Histochem Cytochem. 1998 Apr;46(4):487-96
pubmed: 9524194
J Virol. 2015 Sep;89(17):8982-98
pubmed: 26085152
J Gen Virol. 1995 Jul;76 ( Pt 7):1851-9
pubmed: 9049392
Mol Biol Cell. 2011 Dec;22(23):4602-20
pubmed: 21976701
J Clin Microbiol. 2003 Apr;41(4):1565-8
pubmed: 12682146
J Virol. 2003 Jul;77(13):7601-10
pubmed: 12805460
Anal Chem. 2011 Dec 15;83(24):9344-51
pubmed: 22044264
J Immunol. 1995 Oct 1;155(7):3585-92
pubmed: 7561057
J Gen Virol. 1994 May;75 ( Pt 5):1091-9
pubmed: 8176370
J Virol. 2006 Jan;80(1):494-504
pubmed: 16352573
J Biol Chem. 2006 Oct 6;281(40):30223-33
pubmed: 16891305